Quarterly recall events increased for the first time since Q2 2020.
The pandemic put unprecedented pressure on drug and medical device production, underlining the growing challenge of monitoring, analyzing, reporting and acting on quality. It became clearer than ever before that the more fragmented processes become, the more critical it is that they can be assessed and managed for consistent quality. At the same time, innovative tools and best practices have emerged.
President Biden intends to nominate former FDA Commissioner Robert Califf, M.D. as agency head, and the same opposition voiced during his previous nomination remains.
For private equity and venture capital investors alike, there are five key trends presenting both headwinds and tailwinds that may impact investment flows into 2022.
The industry association says the shortage has become a serious, industry-wide problem for companies involved in manufacturing medical technologies.
This article reviews real-world examples of product failures, presents reasons for these failures and provides potential solutions better governance, collaboration, and data gathering throughout the product lifecycle.
The market dynamics for telehealth and virtual care continue to evolve, and virtual care ecosystem players must understand how consumers have experienced these changes to better position themselves and design their solutions.
The talent behind a company’s solutions is its biggest competitive advantage. For many medtech companies, attracting candidates requires taking a fresh look at the recruiting and retention process.
Digital transformation is especially important to medical device manufacturers because they must have good quality data, and especially tracking metrics, to track complaints and device performance to comply with regulatory requirements. And these requirements are just getting stricter.
Growing pressure on the manufacturing industry from rising prices, new regulations and supply chain uncertainty have accelerated medtech’s digital transformation. COVID-19, in particular, has encouraged medical manufacturers to adopt more resilient and agile working practices. New technology can enable process changes and business strategies that help medical manufacturers become more flexible and responsive to changing…
